Northern Trust’s Neurotrope, Inc. Common NTRP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-21,164
| Closed | -$23K | – | 4445 |
|
|
2020
Q3 | $23K | Buy |
21,164
+328
| +2% | +$377 | ﹤0.01% | 4199 |
|
|
2020
Q2 | $24K | Sell |
20,836
-3,442
| -14% | -$4.31K | ﹤0.01% | 4151 |
|
|
2020
Q1 | $20K | Buy |
24,278
+5,618
| +30% | +$6.13K | ﹤0.01% | 4094 |
|
|
2019
Q4 | $18K | Sell |
18,660
-840
| -4% | -$655 | ﹤0.01% | 4169 |
|
|
2019
Q3 | $16K | Sell |
19,500
-1,000
| -5% | -$4.58K | ﹤0.01% | 4170 |
|
|
2019
Q2 | $164K | Hold |
20,500
| – | – | ﹤0.01% | 3862 |
|
|
2019
Q1 | $112K | Sell |
20,500
-6,292
| -23% | -$27.1K | ﹤0.01% | 3902 |
|
|
2018
Q4 | $96K | Hold |
26,792
| – | – | ﹤0.01% | 3931 |
|
|
2018
Q3 | $236K | Buy |
26,792
+6,498
| +32% | +$62.2K | ﹤0.01% | 3818 |
|
|
2018
Q2 | $196K | Buy |
20,294
+4,495
| +28% | +$41.4K | ﹤0.01% | 3865 |
|
|
2018
Q1 | $128K | Buy |
15,799
+2,308
| +17% | +$18.3K | ﹤0.01% | 3922 |
|
|
2017
Q4 | $95K | Sell |
13,491
-518
| -4% | -$3.02K | ﹤0.01% | 3984 |
|
|
2017
Q3 | $73K | Buy |
14,009
+340
| +2% | +$1.78K | ﹤0.01% | 4014 |
|
|
2017
Q2 | $128K | Buy |
+13,669
| New | +$146K | ﹤0.01% | 3915 |
|
Other funds holding NTRP
Northern Trust's NTRP Position: Q4 2020 in Review
Northern Trust sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 21,164 shares — an estimated $23K sold.
Northern Trust first reported a position in NTRP in Q2 2017 and held it in 14 quarters. The position peaked at $236K in Q3 2018. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.
- Northern Trust reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
- Northern Trust sold 21,164 Neurotrope, Inc. Common shares in Q4 2020, an estimated $23K.
- Northern Trust first reported a position in Neurotrope, Inc. Common in Q2 2017 and held it in 14 quarters.
- Northern Trust's Neurotrope, Inc. Common position peaked at $236K in Q3 2018.
- 1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.
Based on Northern Trust's 13F filing for Q4 2020, filed 11 Feb 2021.